The significance of MRD-based strategy by dynamic assessment to guide treatment decisions in B-ALL – the enlightenment provided by demonstrating survival differences in the retrospective study
Purpose: The study aimed to access the impact of related factors on the long-term survival of patients with B-cell acute lymphoblastic leukemia (B-ALL) by analyzing clinical characteristics of B-ALL patients, and observed the significance of dynamic measurable residual disease (MRD) assessment for t...
Saved in:
| Main Authors: | Yongyu Chen, Rongrong Liu, Jing Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Hematology |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/16078454.2024.2415589 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment outcomes for acute T-lymphoblastic leukemias/lymphomas: data from the ALL-2016 multicenter prospective randomized trial
by: O. A. Aleshina, et al.
Published: (2023-03-01) -
Pattern, clinical and laboratory features from of adult acute lymphoblastic leukemia patients from Kurdistan-Iraq
by: Dnya Jaza Mohammed, et al.
Published: (2023-06-01) -
New insights into hematopoietic cell transplantation in ALL: Who should be transplanted, when, and how
by: Daisuke Tomizawa, et al.
Published: (2024-12-01) -
Measurable residual disease in hematologic malignancies: a biomarker in search of a standard
by: Namrata S. Chandhok, et al.
Published: (2025-08-01) -
False-Positive and False-Negative MRD Results in Children with Acute Lymphoblastic Leukemia: Navigating Between Scylla and Charybdis (Brief Review and Clinical Experience)
by: Yulia S. Korkina, et al.
Published: (2025-06-01)